FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

ANDA Transdermal/Topical Delivery Systems Guide

Federal Register notice: FDA releases a revised draft guidance entitled Assessing the Irritation and Sensitization Potential of Transdermal and Topica...

latest-news-card-1
Medical Devices

PTA, Specialty Catheter Submission Guidance

FDA publishes a final guidance with recommendations for 510(k) submissions for peripheral percutaneous transluminal angioplasty balloon and specialty ...

latest-news-card-1
Human Drugs

FDA Rewrites History, Facts in Coreg Label Case: GSK

GlaxoSmithKline asks the Supreme Court not to hear Tevas appeal of an adverse appeals court decision in a skinny label case for its generic form of GS...

latest-news-card-1
Federal Register

Annual Reporting Exemption for 2 Biologic Classes

Federal Register notice: FDA issues a final order to exempt certain categories of biological products from certain annual reporting requirements.

latest-news-card-1
Medical Devices

FDA Accepts De Novo AlgoDx Sepis Detector

FDA accepts for review a AlgoDx de novo marketing request for Navoy Sepsis, a clinical decision support software for predicting sepsis in adult patien...

latest-news-card-1
Medical Devices

FDA Clarifies Philips BiPAP, CPAP Replacement Numbers

FDA says a Philips Web site report on the number of replacement and remediated BiPAP and CPAP devices shipped to consumers overstates the number that ...

latest-news-card-1
Human Drugs

Government Turns to High Court in Mifepristone Appeal

The Justice Department seeks emergency relief from the U.S. Supreme Court after the Fifth Circuit Court of Appeals ruled that the abortion drug mifepr...

latest-news-card-1
Federal Register

Guide on OTC Monograph Order Requests

Federal Register notice: FDA makes available a draft guidance entitled Over-the-Counter Monograph Order Requests (OMORs): Format and Content.

latest-news-card-1
Federal Register

Input Sought on FDA Tech/Data Strategic Plan

Federal Register notice: FDA announces a request for information and comments on the development of an FDA data and technology strategic plan.

latest-news-card-1
Human Drugs

Panels to Consider Rexulti sNDA for Alzheimers Agitation

FDA medical reviewers ask two advisory committees to consider whether there is a population of Alzheimers patients for whom Otsuka and Lundbecks Rexul...